3-chloropropyl(trimethoxy)silane

We are 3-chloropropyl(trimethoxy)silane CAS:2530-87-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:3-chloropropyl(trimethoxy)silane
CAS.NO:2530-87-2
Synonyms:(3-Chloropropyl)trimethoxysilan; 3-chloro-n-propyl-trimethoxysilane;
3-Trimethoxysilylpropyl Chloride;
Molecular Formula:C6H15ClO3Si
Molecular Weight:198.72000
 
Physical and Chemical Properties:
Density:1.09;
Melting point:-50^oC;
Boiling point:192^oC;
Flash point:84^oC;
Index of Refraction:1.419;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used as a coupling agent to improve adhesion of organic resins to inorganic surfaces.
It can be used as an additive in a urethane adhesive formulation. Its addition to the isocyanate prepolymer causes no adverse efect in the prepolymer viscosity.
It can be used as a good coupling agent for epoxy resins to glass in laminates. The resin has good wet out on the treated glass fabric. More important, both flexural strength as well as wet and dry tensile strength are significantly improved over that seen with epoxy and amino functional silanes.
It can be used as an effective coupling agent for treating glass fabric used in polystyrene laminates. The flexural strength of these laminates is unchanged after two hours in boiling water, and the compressive strength slightly improved over that found under dry conditions.
It can be used as an intermediate for other functional organosilane.




Related News: This includes chemical APIs.691007-05-3 Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.1628047-84-6 Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.92-79-5 The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.